SCM Lifescience Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	157.19	49.59	4,496	6,916	2,890	77.47
Short-Term Investments	11,405	870.16	7,840	2,053	16,754	35,219
Cash & Short-Term Investments	11,563	919.76	12,336	8,970	19,644	35,297
Cash Growth	76.59%	-92.54%	37.52%	-54.34%	-44.35%	46.95%
Accounts Receivable	717.25	48.8	106.41	5.63	16.8	18.59
Other Receivables	39.02	86.81	19.91	19.7	72.87	59.18
Receivables	756.27	135.62	126.32	25.34	89.66	77.77
Inventory	409.21	535.02	392.06	102.71	279.68	36.02
Prepaid Expenses	19.88	283.65	264.78	227.82	223	311.73
Other Current Assets	88.05	122.03	141.25	714.15	75.52	363.66
Total Current Assets	12,836	1,996	13,260	10,040	20,312	36,086
Property, Plant & Equipment	11,993	20,450	10,254	10,650	11,117	11,544
Long-Term Investments	-	-	1,085	11,468	21,654	28,167
Other Intangible Assets	439.24	695.97	236.93	302.73	335.32	359.17
Other Long-Term Assets	3,192	27.28	567.69	559.11	627.01	136.21
Total Assets	28,461	23,170	25,404	33,020	54,045	76,292
Accrued Expenses	93.92	180.63	180.44	107.3	232.79	224.61
Short-Term Debt	-	-	-	2,000	-	-
Current Portion of Long-Term Debt	-	3,630	-	-	5,820	120
Current Portion of Leases	590.63	160.06	131.05	61.56	269.68	330.72
Other Current Liabilities	1,258	1,770	836.73	2,393	2,387	2,584
Total Current Liabilities	1,942	5,741	1,148	4,562	8,709	3,259
Long-Term Debt	-	3,150	3,630	3,630	-	5,820
Long-Term Leases	2,074	26.32	57.02	77.55	81.12	368.64
Other Long-Term Liabilities	70.03	73.84	95.01	239.21	641.8	3,765
Total Liabilities	4,086	8,991	4,930	8,509	9,432	13,213
Common Stock	16,378	10,234	10,234	6,060	6,011	5,937
Additional Paid-In Capital	184,165	178,577	178,514	163,098	161,784	160,144
Retained Earnings	-178,882	-183,364	-170,987	-147,026	-124,096	-101,577
Treasury Stock	-16.56	-16.56	-16.56	-	-	-
Comprehensive Income & Other	2,730	8,749	2,730	2,378	913.54	-1,425
Total Common Equity	24,375	14,179	20,474	24,511	44,613	63,079
Shareholders' Equity	24,375	14,179	20,474	24,511	44,613	63,079
Total Liabilities & Equity	28,461	23,170	25,404	33,020	54,045	76,292
Total Debt	2,664	6,966	3,818	5,769	6,171	6,639
Net Cash (Debt)	8,898	-6,047	8,518	3,201	13,473	28,658
Net Cash Growth	265.70%	-	166.12%	-76.24%	-52.99%	69.77%
Net Cash Per Share	391.84	-295.53	520.41	220.68	1126.01	2701.30
Filing Date Shares Outstanding	32.75	20.46	20.46	14.54	14.43	14.25
Total Common Shares Outstanding	32.75	20.46	20.46	14.54	14.43	14.25
Working Capital	10,894	-3,745	12,112	5,478	11,602	32,827
Book Value Per Share	744.27	692.98	1000.63	1685.22	3092.46	4426.77
Tangible Book Value	23,936	13,483	20,237	24,208	44,277	62,720
Tangible Book Value Per Share	730.86	658.97	989.05	1664.40	3069.22	4401.57
Land	1,375	13,648	6,967	6,967	6,967	6,967
Buildings	3,228	2,117	2,117	2,117	2,117	2,114
Machinery	1,554	3,590	3,561	3,472	3,318	2,762
Construction In Progress	-	4,498	640.2	577.31	304.92	293.57

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.